Alagille syndrome medical therapy: Difference between revisions

Jump to navigation Jump to search
Kristin Feeney (talk | contribs)
No edit summary
Vanbot (talk | contribs)
m Robot: Changing Category:Mature chapter to Category:Overview complete
Line 14: Line 14:
==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WS}}


[[Category:Pediatrics]]
[[Category:Pediatrics]]
Line 20: Line 22:
[[Category:Rare diseases]]
[[Category:Rare diseases]]
[[Category:Hepatology]]
[[Category:Hepatology]]
[[Category:Mature chapter]]
[[Category:Overview complete]]
 
{{WH}}
{{WS}}

Revision as of 18:30, 17 April 2012

Alagille syndrome Microchapters

Home

Patient Info

Overview

Historical Perspective

Pathophysiology

Epidemiology & Demographics

Risk Factors

Causes

Differentiating Alagille syndrome from other Diseases

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alagille syndrome medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Alagille syndrome medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alagille syndrome medical therapy

CDC on Alagille syndrome medical therapy

Alagille syndrome medical therapy in the news

Blogs on Alagille syndrome medical therapy

Directions to Hospitals Treating Alagille syndrome

Risk calculators and risk factors for Alagille syndrome medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Alagille syndrome may be managed through medical therapies that involve improving bile flow and reducing itching. There is controversy over the degree of success of such treatments.

Medical Therapy

The medical management of Alagille Syndrome is complex and continues to generate controversy. The significant variability of organ involvement requires the managing physician to have an understanding of the breadth and interplay of the variable manifestations. Furthermore, the liver disease in particular requires an appreciation of the natural history and evolution of the profound cholestasis.

Several medications are used to improve bile flow and reduce itching (pruritus): Ursodiol (Actigall),Hydroxyzine (Atarax), Cholestyramine, Rifampicin, and Phenobarbitol have all been used to varying degrees of success.

Many patients with Alagille's Syndrome will also benefit from a high dose of a multivitamin such as ADEK (contining high levels of vitamins A, D, E, and K), as the reduced bile flow makes it difficult to absorb and utilize these vitamins.It is equally important to optimize nutrition to maximize growth and development. Those with splenomegaly need to use spleen guard during activnities. Routine follow up with a pediatrician is necessary.

References

Template:WH Template:WS